These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 27335374)

  • 21. Vascular Calcification: An Important Understanding in Nephrology.
    Zununi Vahed S; Mostafavi S; Hosseiniyan Khatibi SM; Shoja MM; Ardalan M
    Vasc Health Risk Manag; 2020; 16():167-180. PubMed ID: 32494148
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical practice guidelines for the prevention, diagnosis, evaluation and treatment of mineral and bone disorders in chronic kidney disease (CKD-MBD) in adults.
    Bellorin-Font E; Ambrosoni P; Carlini RG; Carvalho AB; Correa-Rotter R; Cueto-Manzano A; Jara A; Jorgetti V; Negri AL; Olaizola I; Salusky I; Slatopolsky E; Weisinger JR; ;
    Nefrologia; 2013; 33 Suppl 1():1-28. PubMed ID: 23629678
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Bone mineral metabolism in patients with chronic kidney disease: review of its pathophysiology and morbimortality].
    Bernuy J; Gonzales GF
    Rev Peru Med Exp Salud Publica; 2015; 32(2):326-34. PubMed ID: 26338395
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pathophysiology of the chronic kidney disease-mineral bone disorder.
    Hruska KA; Seifert M; Sugatani T
    Curr Opin Nephrol Hypertens; 2015 Jul; 24(4):303-9. PubMed ID: 26050115
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Supplementary nutrients for prevention of vascular calcification in patients with chronic kidney disease.
    Lee SM; An WS
    Korean J Intern Med; 2019 May; 34(3):459-469. PubMed ID: 31048656
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Current concepts and management strategies in chronic kidney disease-mineral and bone disorder.
    Chauhan V; Kelepouris E; Chauhan N; Vaid M
    South Med J; 2012 Sep; 105(9):479-85. PubMed ID: 22948328
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vascular calcification in chronic kidney disease: a review.
    de Oliveira RB; Okazaki H; Stinghen AE; Drüeke TB; Massy ZA; Jorgetti V
    J Bras Nefrol; 2013; 35(2):147-61. PubMed ID: 23812573
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vitamin D and vascular calcification in chronic kidney disease.
    Rodriguez M; Martinez-Moreno JM; Rodríguez-Ortiz ME; Muñoz-Castañeda JR; Almaden Y
    Kidney Blood Press Res; 2011; 34(4):261-8. PubMed ID: 21691129
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanisms of arterial calcifications and consequences for cardiovascular function.
    London GM
    Kidney Int Suppl (2011); 2013 Dec; 3(5):442-445. PubMed ID: 25019027
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antihypertensive treatment with hydrochlorothiazide-hydralazine combination aggravates medial vascular calcification in CKD rats with mineral bone disorder.
    Larivière R; Ung RV; Picard S; Richard DE; Mac-Way F; Agharazii M
    Front Cardiovasc Med; 2023; 10():1241943. PubMed ID: 37840953
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vascular calcification: pathophysiology and risk factors.
    Chen NX; Moe SM
    Curr Hypertens Rep; 2012 Jun; 14(3):228-37. PubMed ID: 22476974
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bone alkaline phosphatase in CKD-mineral bone disorder.
    Sardiwal S; Magnusson P; Goldsmith DJ; Lamb EJ
    Am J Kidney Dis; 2013 Oct; 62(4):810-22. PubMed ID: 23623575
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mineral and bone disorders in chronic kidney disease: new insights into mechanism and management.
    Lewis R
    Ann Clin Biochem; 2012 Sep; 49(Pt 5):432-40. PubMed ID: 22807503
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiorenal Syndrome in End-Stage Kidney Disease.
    Tsuruya K; Eriguchi M; Yamada S; Hirakata H; Kitazono T
    Blood Purif; 2015; 40(4):337-43. PubMed ID: 26657922
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Kidney and bone update : the 5-year history and future of CKD-MBD. Bisphosphonates treatment for chronic kidney disease-mineral and bone disorder].
    Mori H; Okada Y; Tanaka Y; Hashimoto O
    Clin Calcium; 2012 Jul; 22(7):1034-42. PubMed ID: 22750936
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recovery versus persistence of disordered mineral metabolism in kidney transplant recipients.
    Evenepoel P
    Semin Nephrol; 2013 Mar; 33(2):191-203. PubMed ID: 23465505
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiovascular disease in an adenine-induced model of chronic kidney disease: the temporal link between vascular calcification and haemodynamic consequences.
    Shobeiri N; Pang J; Adams MA; Holden RM
    J Hypertens; 2013 Jan; 31(1):160-8. PubMed ID: 23183279
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Breast arterial calcification in chronic kidney disease: absence of smooth muscle apoptosis and osteogenic transdifferentiation.
    O'Neill WC; Adams AL
    Kidney Int; 2014 Mar; 85(3):668-76. PubMed ID: 24048381
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Role of AGEs-RAGE system in CKD-MBD.].
    Fujisawa H; Nakayama Y; Ueda K; Fukami K
    Clin Calcium; 2019; 29(2):193-198. PubMed ID: 30679400
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiovascular calcifications in chronic kidney disease: Potential therapeutic implications.
    Bover J; Ureña-Torres P; Górriz JL; Lloret MJ; da Silva I; Ruiz-García C; Chang P; Rodríguez M; Ballarín J
    Nefrologia; 2016; 36(6):597-608. PubMed ID: 27595517
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.